Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 53% ± 16% | |
lung | 19 studies | 56% ± 21% | |
bone marrow | 6 studies | 39% ± 15% | |
lymph node | 6 studies | 39% ± 18% | |
uterus | 6 studies | 54% ± 14% | |
intestine | 5 studies | 40% ± 11% | |
kidney | 5 studies | 32% ± 14% | |
placenta | 5 studies | 63% ± 31% | |
adipose | 5 studies | 34% ± 15% | |
esophagus | 5 studies | 56% ± 24% | |
liver | 5 studies | 33% ± 19% | |
skin | 5 studies | 48% ± 20% | |
breast | 5 studies | 45% ± 15% | |
prostate | 4 studies | 64% ± 14% | |
ovary | 3 studies | 33% ± 2% | |
heart | 3 studies | 25% ± 5% | |
thymus | 3 studies | 36% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 16626.34 | 647 / 653 | 87% | 830.52 | 529 / 605 |
esophagus | 100% | 177729.21 | 1438 / 1445 | 84% | 710.38 | 153 / 183 |
lung | 100% | 28324.39 | 577 / 578 | 83% | 359.02 | 960 / 1155 |
skin | 99% | 23459.41 | 1797 / 1809 | 76% | 220.02 | 360 / 472 |
ovary | 88% | 8025.44 | 159 / 180 | 81% | 152.30 | 348 / 430 |
uterus | 82% | 10469.86 | 139 / 170 | 85% | 564.86 | 391 / 459 |
breast | 100% | 32027.24 | 458 / 459 | 64% | 104.75 | 714 / 1118 |
bladder | 95% | 12210.10 | 20 / 21 | 63% | 245.35 | 315 / 504 |
prostate | 96% | 10171.37 | 234 / 245 | 62% | 86.96 | 312 / 502 |
kidney | 36% | 3293.57 | 32 / 89 | 79% | 152.54 | 711 / 901 |
intestine | 78% | 8893.81 | 754 / 966 | 36% | 99.72 | 192 / 527 |
adipose | 100% | 41219.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 27445.33 | 1330 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 966.68 | 44 / 45 |
pancreas | 2% | 110.05 | 5 / 328 | 88% | 253.57 | 156 / 178 |
stomach | 42% | 4916.65 | 149 / 359 | 31% | 47.95 | 90 / 286 |
peripheral blood | 71% | 16251.20 | 661 / 929 | 0% | 0 | 0 / 0 |
spleen | 65% | 4944.60 | 157 / 241 | 0% | 0 | 0 / 0 |
heart | 59% | 5192.77 | 510 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 1929.86 | 76 / 258 | 17% | 24.94 | 40 / 230 |
brain | 6% | 612.95 | 163 / 2642 | 39% | 111.97 | 274 / 705 |
muscle | 9% | 640.64 | 74 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 6.03 | 2 / 29 |
liver | 1% | 182.87 | 3 / 226 | 4% | 8.51 | 17 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 3.39 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001780 | Biological process | neutrophil homeostasis |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0046883 | Biological process | regulation of hormone secretion |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0018149 | Biological process | peptide cross-linking |
GO_0031340 | Biological process | positive regulation of vesicle fusion |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0045629 | Biological process | negative regulation of T-helper 2 cell differentiation |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0090050 | Biological process | positive regulation of cell migration involved in sprouting angiogenesis |
GO_0002250 | Biological process | adaptive immune response |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0033031 | Biological process | positive regulation of neutrophil apoptotic process |
GO_0002685 | Biological process | regulation of leukocyte migration |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0006909 | Biological process | phagocytosis |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0014839 | Biological process | myoblast migration involved in skeletal muscle regeneration |
GO_0008360 | Biological process | regulation of cell shape |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_0045627 | Biological process | positive regulation of T-helper 1 cell differentiation |
GO_0071621 | Biological process | granulocyte chemotaxis |
GO_0045920 | Biological process | negative regulation of exocytosis |
GO_0046632 | Biological process | alpha-beta T cell differentiation |
GO_0002548 | Biological process | monocyte chemotaxis |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0032652 | Biological process | regulation of interleukin-1 production |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0042119 | Biological process | neutrophil activation |
GO_0097350 | Biological process | neutrophil clearance |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0012506 | Cellular component | vesicle membrane |
GO_0031514 | Cellular component | motile cilium |
GO_0031901 | Cellular component | early endosome membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005884 | Cellular component | actin filament |
GO_0005925 | Cellular component | focal adhesion |
GO_0001533 | Cellular component | cornified envelope |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0001891 | Cellular component | phagocytic cup |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005768 | Cellular component | endosome |
GO_0031982 | Cellular component | vesicle |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0008289 | Molecular function | lipid binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0019834 | Molecular function | phospholipase A2 inhibitor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ANXA1 |
Protein name | ANXA1 protein Annexin Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26] |
Synonyms | LPC1 ANX1 hCG_17305 |
Description | FUNCTION: Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity . Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T-cells . Promotes the differentiation of T-cells into Th1 cells and negatively regulates differentiation into Th2 cells . Has no effect on unstimulated T cells . Negatively regulates hormone exocytosis via activation of the formyl peptide receptors and reorganization of the actin cytoskeleton . Has high affinity for Ca(2+) and can bind up to eight Ca(2+) ions (By similarity). Displays Ca(2+)-dependent binding to phospholipid membranes . Plays a role in the formation of phagocytic cups and phagosomes. Plays a role in phagocytosis by mediating the Ca(2+)-dependent interaction between phagosomes and the actin cytoskeleton (By similarity). .; FUNCTION: [Annexin Ac2-26]: Functions at least in part by activating the formyl peptide receptors and downstream signaling cascades . Promotes chemotaxis of granulocytes and monocytes via activation of the formyl peptide receptors . Promotes rearrangement of the actin cytoskeleton, cell polarization and cell migration . Promotes resolution of inflammation and wound healing . Acts via neutrophil N-formyl peptide receptors to enhance the release of CXCL2 . . |
Accessions | Q5TZZ9 ENST00000257497.11 ENST00000415424.5 ENST00000456643.5 Q05BR2 P04083 Q5T3N0 ENST00000376911.1 Q5T3N1 |